Comparative efficacy and safety of antiplatelet agents in cerebral ischemic disease: A network meta‐analysis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.26065
Abstract: We performed a network meta‐analysis (NMA) to enhance the corresponding evidence of the relative efficacy and safety of different antiplatelet agents in cerebral ischemic disease. PubMed and EMBASE were searched systematically for relevant studies. Outcomes… read more here.
Keywords: cerebral ischemic; efficacy safety; safety; network meta ... See more keywords
Impact of antiplatelet agents and anticoagulants on the performance of fecal immunochemical tests: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2021 at "Surgical Endoscopy"
DOI: 10.1007/s00464-021-08774-7
Abstract: Antithrombotic agents may increase the bleeding tendency and affect the performance of fecal immunochemical test (FIT). We aimed to evaluate the impact of antithrombotic agents on the performance of FIT through a systematic review and… read more here.
Keywords: analysis; antiplatelet agents; performance fecal; meta analysis ... See more keywords
Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-021-02558-5
Abstract: SARS-CoV-2 represents the causative agent of the current pandemic (COVID-19). The drug repurposing technique is used to search for possible drugs that can bind to SARS-CoV-2 proteins and inhibit viral replication. In this study, the… read more here.
Keywords: properties antiplatelet; potential antiviral; silico; sars cov ... See more keywords
Identification of novel antiplatelet agents by targeting Glycoprotein VI: A combined virtual screening study.
Sign Up to like & getrecommendations! Published in 2022 at "Bioorganic chemistry"
DOI: 10.1016/j.bioorg.2022.105661
Abstract: Cardiovascular diseases are the primary reason for deaths in the world. However, antiplatelet drugs in the market have limitations in use because of the risk of increased bleeding and other side effects that impair primary… read more here.
Keywords: study; antiplatelet agents; combined virtual; virtual screening ... See more keywords
Synthesis, Bioevaluation, Structure-Activity Relationship and Docking Studies of Natural Product Inspired (Z)-3-benzylideneisobenzofuran-1(3H)-ones as Highly Potent antioxidants and Antiplatelet agents
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-59218-6
Abstract: For the first time, a series of highly potent natural product inspired substituted (Z)-3-benzylideneisobenzofuran-1(3H)-ones 28a-t, embraced with electron-withdrawing groups (EWG) and electron-donating groups (EDG) at site I and site II, were prepared and assessed for… read more here.
Keywords: highly potent; antiplatelet agents; product inspired; natural product ... See more keywords
Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis and haemostasis"
DOI: 10.1055/a-1414-5009
Abstract: Early recanalization of the infarct-related artery to achieve myocardial reperfusion is the primary therapeutic goal in patients with ST-elevation myocardial infarction (STEMI). In order to decrease the duration of ischemia, continuous efforts have been made… read more here.
Keywords: stemi; pre hospital; antiplatelet; antiplatelet therapy ... See more keywords
Outcome of traumatic brain injury in patients on antiplatelet agents: a retrospective 20-year observational study in a single neurosurgery unit
Sign Up to like & getrecommendations! Published in 2017 at "Brain Injury"
DOI: 10.1080/02699052.2017.1377349
Abstract: ABSTRACT Objective: To evaluate the outcomes after Traumatic Brain Injury (TBI) in patients taking Antiplatelet Agents (APAs). Methods: We reviewed the clinical records of 934 patients with TBI between 1995 and 2014. Multivariate analysis was… read more here.
Keywords: traumatic brain; mortality; brain injury; injury ... See more keywords
Laboratory Monitoring of Platelet P2Y12 Receptor Inhibitors and Reversal of Antiplatelet Agents.
Sign Up to like & getrecommendations! Published in 2019 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqy151
Abstract: OBJECTIVES To review the use of laboratory tests for antiplatelet agents to determine escalation of antiplatelet therapy and for emergent reversal of P2Y12 inhibitors. METHODS A case scenario and review of cardiovascular and neurointerventional literature… read more here.
Keywords: monitoring platelet; p2y12; laboratory monitoring; platelet ... See more keywords
The Use of Antiplatelet Agents and Heparin in the 24-Hour Postintravenous Alteplase Window for Neurointervention.
Sign Up to like & getrecommendations! Published in 2021 at "Neurosurgery"
DOI: 10.1093/neuros/nyaa530
Abstract: BACKGROUND Intravenous (IV) alteplase with mechanical thrombectomy has been found to be superior to alteplase alone in select patients with intracranial large vessel occlusion. Current guidelines discourage the use of antiplatelet agents or heparin for… read more here.
Keywords: alteplase; use antiplatelet; antiplatelet agents; agents heparin ... See more keywords
Novel Antithrombotic Agents in Pregnancy Anticoagulants and Antiplatelet Agents.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical obstetrics and gynecology"
DOI: 10.1097/grf.0000000000000740
Abstract: Increasing rates of thromboembolic complications have required increasing use of anticoagulant and antiplatelet agents during and after pregnancy. Furthermore, thromboembolism is both a cause and a complication of severe maternal morbidity requiring intensive care. As… read more here.
Keywords: novel antithrombotic; antiplatelet agents; anticoagulants antiplatelet; agents pregnancy ... See more keywords
Comparison between thromboelastography and the conventional coagulation test in detecting effects of antiplatelet agents after endovascular treatments in acute ischemic stroke patients
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000019447
Abstract: Abstract Antiplatelet agents have been administered to patients with acute ischemic stroke after endovascular therapy. This study was designed to provide initial data to compare thromboelastography (TEG) with the conventional coagulation test (CCT) to analyze… read more here.
Keywords: antiplatelet agents; ischemic stroke; acute ischemic; conventional coagulation ... See more keywords